Literature DB >> 28930592

Choline, the brain and neurodegeneration: insights from epigenetics.

Rola A Bekdash1.   

Abstract

Neurodegenerative disorders are a major public health problem worldwide with huge socioeconomic effect. Recent evidence suggests that neurodegeneration is not only caused by genetic factors but also affected by environmental factors including nutrients. Environmental influences have been shown to cause epigenetic modifications in the brain with long-lasting effects on behavior if they occur in early life. It has been suggested that early nutritional intervention that includes choline, betaine, VitB6, VitB12 and/or folic acid could attenuate decline in cognitive functions. Recently, choline emerged as an essential micronutrient for normal brain development and an epigenetic modifier of the genome that could alter neuronal gene methylation, expression and activity. Choline maintains the structural and functional integrity of membranes and regulates cholinergic neurotransmission via the synthesis of acetylcholine. Choline-related functions have been shown to be dysregulated in several neurodegenerative disorders suggesting a potential role of nutrients in mental health. We will discuss the role of epigenetic mechanisms in neurodegeneration and how nutrients could interact with the epigenome to protect or boost cognitive processes across the lifespan.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28930592     DOI: 10.2741/4636

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  8 in total

Review 1.  Neuroprotective Effects of Choline and Other Methyl Donors.

Authors:  Rola A Bekdash
Journal:  Nutrients       Date:  2019-12-06       Impact factor: 5.717

2.  A new rat model of creatine transporter deficiency reveals behavioral disorder and altered brain metabolism.

Authors:  Lara Duran-Trio; Gabriella Fernandes-Pires; Dunja Simicic; Jocelyn Grosse; Clothilde Roux-Petronelli; Stephen J Bruce; Pierre-Alain Binz; Carmen Sandi; Cristina Cudalbu; Olivier Braissant
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

3.  Metabolomic and lipidomic characterization of an X-chromosome deletion disorder in neural progenitor cells by UHPLC-HRMS.

Authors:  Hoda Safari Yazd; Vanessa Y Rubio; Casey A Chamberlain; Richard A Yost; Timothy J Garrett
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-05-29

4.  Hydrogen Sulfide Ameliorated High Choline-Induced Cardiac Dysfunction by Inhibiting cGAS-STING-NLRP3 Inflammasome Pathway.

Authors:  Lu Bai; Jing Dai; Yuxuan Xia; Kaichuan He; Hongmei Xue; Qi Guo; Danyang Tian; Lin Xiao; Xiangjian Zhang; Xu Teng; Yuming Wu; Sheng Jin
Journal:  Oxid Med Cell Longev       Date:  2022-07-22       Impact factor: 7.310

Review 5.  Choline, Neurological Development and Brain Function: A Systematic Review Focusing on the First 1000 Days.

Authors:  Emma Derbyshire; Rima Obeid
Journal:  Nutrients       Date:  2020-06-10       Impact factor: 5.717

Review 6.  The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.

Authors:  Natalia Arias; Silvia Arboleya; Joseph Allison; Aleksandra Kaliszewska; Sara G Higarza; Miguel Gueimonde; Jorge L Arias
Journal:  Nutrients       Date:  2020-08-05       Impact factor: 5.717

7.  Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.

Authors:  Uma V Mahajan; Vijay R Varma; Michael E Griswold; Chad T Blackshear; Yang An; Anup M Oommen; Sudhir Varma; Juan C Troncoso; Olga Pletnikova; Richard O'Brien; Timothy J Hohman; Cristina Legido-Quigley; Madhav Thambisetty
Journal:  PLoS Med       Date:  2020-01-24       Impact factor: 11.069

8.  Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R).

Authors:  Giacomo Rossino; Marta Rui; Luca Pozzetti; Dirk Schepmann; Bernhard Wünsch; Daniele Zampieri; Giorgia Pellavio; Umberto Laforenza; Silvia Rinaldi; Giorgio Colombo; Laura Morelli; Pasquale Linciano; Daniela Rossi; Simona Collina
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.